Viewing Study NCT02092792


Ignite Creation Date: 2025-12-24 @ 3:21 PM
Ignite Modification Date: 2026-01-13 @ 11:14 PM
Study NCT ID: NCT02092792
Status: COMPLETED
Last Update Posted: 2020-02-12
First Post: 2014-03-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Evaluating the Safety of Escalating Doses of DLYE5953A in Patients With Refractory Solid Tumors
Sponsor: Genentech, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-04-01
Start Date Type: ACTUAL
Primary Completion Date: 2017-07-10
Primary Completion Date Type: ACTUAL
Completion Date: 2017-07-10
Completion Date Type: ACTUAL
First Submit Date: 2014-03-18
First Submit QC Date: None
Study First Post Date: 2014-03-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-02-10
Last Update Post Date: 2020-02-12
Last Update Post Date Type: ACTUAL